Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Proponents often emphasize the potential for meaningful therapeutic benefits, especially in diseases where conventional medications have proven limited. However, crucially important to evaluate the significant financial investment associated with